| pubmed-article:9075786 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C0027651 | lld:lifeskim |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C0086418 | lld:lifeskim |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C0040052 | lld:lifeskim |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C1280500 | lld:lifeskim |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C0018270 | lld:lifeskim |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C1947989 | lld:lifeskim |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C1533691 | lld:lifeskim |
| pubmed-article:9075786 | lifeskim:mentions | umls-concept:C0205225 | lld:lifeskim |
| pubmed-article:9075786 | pubmed:issue | 2 | lld:pubmed |
| pubmed-article:9075786 | pubmed:dateCreated | 1997-4-8 | lld:pubmed |
| pubmed-article:9075786 | pubmed:abstractText | A study was made of the in vitro effects of recombinant human megakaryocyte growth and development factor (PEG-rHuMGDF) on breast, prostate, cervix and colon cancers. Tumour growth was assessed using a soft agar clonogenic assay. Stimulation of megakaryocyte numbers was seen in liquid culture following 10 ng/ml PEG-rHuMGDF. The same concentration led to no significant difference in colony-forming efficiencies for 22 of 25 tumour samples. A significant reduction in colony-forming efficiencies was seen for the remaining 3 specimens. These results suggest that PEG-rHuMGDF will not stimulate tumour growth in vivo. | lld:pubmed |
| pubmed-article:9075786 | pubmed:language | eng | lld:pubmed |
| pubmed-article:9075786 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9075786 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:9075786 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9075786 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9075786 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:9075786 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:9075786 | pubmed:issn | 0030-2414 | lld:pubmed |
| pubmed-article:9075786 | pubmed:author | pubmed-author:JonesLL | lld:pubmed |
| pubmed-article:9075786 | pubmed:author | pubmed-author:WestC MCM | lld:pubmed |
| pubmed-article:9075786 | pubmed:author | pubmed-author:BrooksBB | lld:pubmed |
| pubmed-article:9075786 | pubmed:author | pubmed-author:LangS HSH | lld:pubmed |
| pubmed-article:9075786 | pubmed:author | pubmed-author:TestaN GNG | lld:pubmed |
| pubmed-article:9075786 | pubmed:author | pubmed-author:KasperCC | lld:pubmed |
| pubmed-article:9075786 | pubmed:author | pubmed-author:deWynterEE | lld:pubmed |
| pubmed-article:9075786 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:9075786 | pubmed:volume | 54 | lld:pubmed |
| pubmed-article:9075786 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:9075786 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:9075786 | pubmed:pagination | 141-5 | lld:pubmed |
| pubmed-article:9075786 | pubmed:dateRevised | 2006-11-15 | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:meshHeading | pubmed-meshheading:9075786-... | lld:pubmed |
| pubmed-article:9075786 | pubmed:articleTitle | In vitro effects of recombinant human megakaryocyte growth and development factor on primary human tumour colony growth. | lld:pubmed |
| pubmed-article:9075786 | pubmed:affiliation | CRC Department of Experimental Haematology, Christie Hospital, Manchester, UK. | lld:pubmed |
| pubmed-article:9075786 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:9075786 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
